Patient involvement in clinical research: why, when and how. Sacristán JA. Et al. Patient preference and adherence, volume 10 631-40, April 2016.

In the last decades, health care systems have been considering patient goals and preferences when providing them with medical care. However, patients still don’t have an active role in the research process, missing the chance to obtain more relevant knowledge about diseases. This gap is also present in Inflammatory Bowel Disease, a condition that isn’t completely understood and that needs new drugs to offer effective treatments to patients.

This paper describes why patient engagement is important in research and gives examples of how they could participate. Researchers conclude that providing adequate and complete information about clinical research and their results could be the key to achieving better patient involvement.

Crohn’s disease and ulcerative colitis patient perspectives on participation in IBD clinical trials. Ehrlich O. et al. Inflammatory Bowel Diseases, volume 24, issue suppl_1, February 2018.

The therapeutic options for Inflammatory Bowel Disease (IBD) patients have increased substantially in the last few years. However, many patients still don’t respond to any of them or the treatment stops being effective over time. Therefore, there is an urgent need to develop new IBD treatments and for this, clinical trials are indispensable.  However, the recruitment for these trials is often difficult and hampers the development of new treatments. To improve the recruitment process, understanding patient perceptions of clinical trials is of paramount importance.

In this study, researchers examine the challenges and barriers to IBD patient enrolment in clinical trials. This includes the fear and misunderstanding of clinical trials, the time constraints and the influence and relationship with their doctors. Authors also discuss different methods to overcome these barriers.